Rob Ball

Mr. Ball most recently served at Tornier as Global Vice President, Research and Development from 2006 through 2013. During this time, Tornier grew from approximately $70M to $300M in annual revenues, meaningfully through organic growth of new products. Rob had prior roles leading R&D at Kinetikos Medical Inc (acquired by Integra Life Sciences), DePuy-Synthes, and in the automotive industry. Rob holds a BSME and MSME from Kettering University and holds over 30 issued or pending patents.